03347.HK
Hangzhou Tigermed Consulting Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 45.30
−0.74%Sep 11, 2026, 10:15 UTC
China's Zhejiang Securities Regulatory Bureau issued warning letters and a prior notice of administrative penalty to Tigermed's actual controllers Ye Xiaoping and Cao Xiaochun over late disclosure of shareholding changes.
Aug 28, 2026, 08:53 UTC
Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.